Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214224 · ClinicalTrials.gov registry record · NA
Remote Pulmonary Function Testing in Amyotrophic Lateral Sclerosis (Pilot)
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03214224 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT03214224, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The specific objective of this study is to validate the practice of remote pulmonary function testing (rPFT) conducted in the home through the use of connected mobile health devices and the Penn State Hershey ALS Telemanagement program.
Interventions
- DEVICE remote pulmonary function testing
- DEVICE standard pulmonary function testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03214224
The ClinicalTrials.gov registry entry for NCT03214224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which remote pulmonary function testing is the first listed.
NCT03214224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03214224 about?
NCT03214224 is a clinical study titled "Remote Pulmonary Function Testing in Amyotrophic Lateral Sclerosis (Pilot)". The specific objective of this study is to validate the practice of remote pulmonary function testing (rPFT) conducted in the home through the use of connected mobile health devices and the Penn State Hershey ALS Telemanagement program.
What is the current status of trial NCT03214224?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2017-11-01. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03214224?
The interventions under investigation include: remote pulmonary function testing (DEVICE), standard pulmonary function testing (DEVICE).
Who is sponsoring clinical trial NCT03214224?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.